Pardafas Reporter
The Tizig Pharma initiated distribution of the drug introduced in the country to make them easily available to patients battling the deadly non-communicable disease. This has ended the compulsion for Nepali cancer patients to procure expensive drugs from abroad.
A factory was set up in Kavrepalanchowk district after inking a technology transfer agreement with an Indian pharmaceutical company. Accure Labs Pvt. Ltd. has begun manufacturing the drug in tablet and capsule form.
The authorities are considering producing the anti-cancer drug in injection form too. The company claims that domestically produced drugs will be less costly than those brought from abroad. Furthermore, there will be less possibility for drug shortage in the market as production has begun locally.
Manufacturing of other medicines are not permitted in the factory which manufactures anti-cancer drugs, due to toxicity.
Bharatpur Cancer Hospital's executive chairperson Dr. Bishnu Dutta Poudel said it was a very good development that anti-cancer drugs were being manufactured in Nepal. He suggested the manufacturers pay attention to the quality of the drugs.
Similarly, oncologist Dr. Madan Piya echoed the jubilant sentiments with Dr. Poudel that anti-cancer drugs were now being manufactured in Nepal and viewed that priority should be accorded to the Nepalis for consumption of those drugs.
Likewise, Association of Pharmaceutical Producers of Nepal chairperson Prajwal Jung Pandey asserted that the production of anti-cancer drugs in Nepal showed that Nepal could manufacture any sort of drugs. He pointed out the need to make Nepal self-reliant in drugs by manufacturing drugs like anti-cancer drugs.
Department of Drug Administration's Santosh KC urged the manufacturers of anti-cancer drugs to ensure the quality of the drugs. Tigiz Pharma said it has obtained approval for 27 molecules from the Department of Drug Administration for manufacturing of anti-cancer drugs.
